Evidence map›Paper›PMID 37491745›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting.

M McNair, M Porter, T Isaacs, K Pillay, G Williams, R Roberts, J Peter, R J Lehloenya

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

M McNairFaculty of Health Sciences.
M PorterDivision of Dermatology, Department of Medicine, Faculty of Health Sciences.
T IsaacsDivision of Dermatology, Department of Medicine, Faculty of Health Sciences.
K PillayDivision of Anatomical Pathology, Department of Pathology, Faculty of Health Sciences.
G WilliamsFaculty of Health Sciences.
R RobertsDivision of Anatomical Pathology, Department of Pathology, Faculty of Health Sciences.
J PeterDivision of Allergy and Clinical Immunology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
R J LehloenyaDivision of Dermatology, Department of Medicine, Faculty of Health Sciences.
Faculty of Public Health · GBUniversity of Cape Town · ZA

Funding

Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study)R01AI152183 · NIAID · UNIVERSITY OF CAPE TOWN · PI MEINTJES, GRAEME AYTON, PHILLIPS, ELIZABETH · 2020 to 2025
$1.6M
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)K43TW011178 · FIC · UNIVERSITY OF CAPE TOWN LUNG INSTITUTE · PI PETER, JONATHAN · 2018 to 2022
$648k
FIC NIH HHS K43 TW011178NIAID NIH HHS R01 AI152183
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsDrug EruptionsHIV InfectionsHumansPrevalenceAntitubercular Agents

Identifiers

PMID37491745
PMCPMC10365564
OpenAlexW4385263911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.